Search Results - "La, Mei K."

Analysis of the Role of Hematopoietic Stem-Cell Transplantation in Infants With Acute Lymphoblastic Leukemia in First Remission and MLL Gene Rearrangements: A Report From the Children's Oncology Group by DREYER, Zoann E, DINNDORF, Patricia A, WILLMAN, Cheryl L, CARROLL, Andrew J, BEHM, Fred, SMITH, Franklin O, WOODS, William G, GODDER, Kamar, REAMAN, Gregory H, CAMITTA, Bruce, SATHER, Harland, LA, Mei K, DEVIDAS, Meenakshi, HILDEN, Joanne M, HEEREMA, Nyla A, SANDERS, Jean E, MCGLENNEN, Ron

“…Although the majority of children with acute lymphoblastic leukemia (ALL) are cured with current therapy, the event-free survival (EFS) of infants with ALL,…”
Get full text

Outcome After Relapse Among Children With Standard-Risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study CCG-1952 by MALEMPATI, Suman, GAYNON, Paul S, SATHER, Harland, LA, Mei K, STORK, Linda C

“…The event-free survival (EFS) of children with standard-risk acute lymphoblastic leukemia (SR-ALL) is now more than 80%. However, prognosis after relapse…”
Get full text

Young Adults With Acute Lymphoblastic Leukemia Have an Excellent Outcome With Chemotherapy Alone and Benefit From Intensive Postinduction Treatment: A Report From the Children's Oncology Group by NACHMAN, James B, LA, Mei K, STEINHERZ, Peter G, SEIBEL, Nita L, HUNGER, Stephen P, HEEREMA, Nyla A, GAYNON, Paul S, HASTINGS, Caroline, MATTANO, Leonard A, SATHER, Harland, DEVIDAS, Meenakshi, FREYER, David R

“…Patients 16 to 21 years of age with acute lymphoblastic leukemia (ALL) have an inferior outcome compared with younger children, leading some medical…”
Get full text

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group by Seibel, Nita L., Steinherz, Peter G., Sather, Harland N., Nachman, James B., DeLaat, Cynthia, Ettinger, Lawrence J., Freyer, David R., Mattano, Leonard A., Hastings, Caroline A., Rubin, Charles M., Bertolone, Kathy, Franklin, Janet L., Heerema, Nyla A., Mitchell, Torrey L., Pyesmany, Allan F., La, Mei K., Edens, Cheryl, Gaynon, Paul S.

“…Longer and more intensive postinduction intensification (PII) improved the outcome of children and adolescents with “higher risk” acute lymphoblastic leukemia…”
Get full text

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group by Bostrom, Bruce C., Sensel, Martha R., Sather, Harland N., Gaynon, Paul S., La, Mei K., Johnston, Katherine, Erdmann, Gary R., Gold, Stuart, Heerema, Nyla A., Hutchinson, Raymond J., Provisor, Arthur J., Trigg, Michael E.

“…Conventional therapy for childhood acute lymphoblastic leukemia (ALL) includes prednisone and oral 6-mercaptopurine. Prior observations suggested potential…”
Get full text

Abnormalities of chromosome bands 15q13‐15 in childhood acute lymphoblastic leukemia by Heerema, Nyla A., Sather, Harland N., Sensel, Martha G., La, Mei K. L., Hutchinson, Raymond J., Nachman, James B., Reaman, Gregory H., Lange, Beverly J., Steinherz, Peter G., Bostrom, Bruce C., Gaynon, Paul S., Uckun, Fatih M.

“…BACKGROUND Recurring breakpoints in chromosome bands 15q13‐15 occur infrequently in leukemia. To the authors' knowledge, the clinical significance of these…”
Get full text

Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952 by Bassal, Mylène, La, Mei K., Whitlock, James A., Sather, Harland N., Heerema, Nyla A., Gaynon, Paul S., Stork, Linda C.

“…Background Patients with Down syndrome (DS) and standard risk (SR) acute lymphoblastic leukemia (ALL‐DS) are reported to have inferior event free (EFS) and…”
Get full text

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group by Lange, Beverly J., Bostrom, Bruce C., Cherlow, Joel M., Sensel, Martha G., La, Mei K.L., Rackoff, Wayne, Heerema, Nyla A., Wimmer, Robert S., Trigg, Michael E., Sather, Harland N.

“…Addition of a delayed-intensification (DI) phase after standard induction/consolidation therapy was previously shown to improve outcome for patients younger…”
Get full text

Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group study CCG 1922 by Tolar, Jakub, Bostrom, Bruce C., La, Mei K., Sather, Harland N.

“…Purpose To compare outcomes of patients with NCI standard risk acute lymphoblastic leukemia (ALL) who relapsed after being randomized to receive either oral or…”
Get full text

Survival after Relapse in Higher Risk Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents Is Independent of Prior Treatment Intensity: A Report from the Children's Oncology Group (COG) by Freyer, David Robert, Seibel, Nita L., La, Mei K, Devidas, Meenakshi, Carroll, William L., Hunger, Stephen P., Gaynon, Paul S.

“…While intensification of therapy has improved event-free survival (EFS) and survival in newly diagnosed patients, outcomes after relapse have proved more…”
Get full text

Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children's Oncology Group Study 1991 by Matloub, Yousif, Bostrom, Bruce C., Hunger, Stephen P., Angiolillo, Anne L, Cole, Catherine, Thomson, Blythe, Devidas, Meenakshi, Heerema, Nyla A., La, Mei K, Buckley, Patrick J., Carroll, William L., Winick, Naomi, Sather, Harland, Nachman, James B, Gaynon, Paul S.

“…A substantial number of relapses derive from the NCI standard risk population. CCG-1991 tested two components of the successful COG augmented “BFM” regimen (N…”
Get full text

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy by Cho, Robert, Stork, Linda C., Gaynon, Paul S., Sather, Harland N., La, Mei K., Hutchinson, Raymond J.

“…Microscopic assessment of bone marrow response on Day 7 and/or Day 14 of induction therapy remains a powerful predictor of long-term outcome in childhood acute…”
Get full text

Outcome after Relapse among Children with Standard Risk (SR) ALL Treated on CCG-1952 by Malempati, Suman, Gaynon, Paul S., Sather, Harland, La, Mei K., Stork, Linda C.

“…The event-free survival (EFS) of children with SR-ALL is now > 80%. Nonetheless, ALL relapse remains a major problem in pediatric cancer, and optimal therapy…”
Get full text

Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia : A report from the children's cancer group study CCG 1922 by TOLAR, Jakub, BOSTROM, Bruce C, LA, Mei K, SATHER, Harland N, ZWAAN, C. M, VEERMAN, A. J. P

Get full text